ARTICLE | Preclinical News
Cancer target of alcohol abuse drug disulfiram identified
December 6, 2017 10:52 PM UTC
Palacky University researchers and colleagues provide evidence that the generic alcohol abuse drug disulfiram can be repurposed to treat cancer, and suggest a mechanism of action for the drug's activity.
Disulfiram has recently been investigated for its anti-cancer properties in preclinical and clinical settings. However, the molecular target that gives the drug its anti-cancer properties has remained elusive...
BCIQ Target Profiles